Zobrazeno 1 - 10
of 237
pro vyhledávání: '"D.A.L. Morgan"'
Autor:
A. Bello, R. Karia, Ian O. Ellis, Andrew H S Lee, D.A.L. Morgan, J. Mathew, John F.R. Robertson
Publikováno v:
The Breast. 31:181-185
The aim of our study was to assess various predictors for local recurrence (LR) in patients undergoing breast conservation surgery (BCS) for ductal carcinoma in situ (DCIS).An audit was performed of 582 consecutive patients with DCIS between Jan 1975
Publikováno v:
Scott-Brown’s Otorhinolaryngology Head and Neck Surgery ISBN: 9780203731031
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f28f41812b174f908fb26bc70c91cec0
https://doi.org/10.1201/9780203731031-5
https://doi.org/10.1201/9780203731031-5
Autor:
Dominic A.X. Schinagl, Guus Hart, Alain Fourquet, Harry Bartelink, Paula H.M. Elkhuizen, Philip Poortmans, Jean-Claude Horiot, Youlia M. Kirova, Raymond Miralbell, Vincent Remouchamps, Laurence Collette, Erik van Werkhoven, René-Olivier Mirimanoff, Philippe Maingon, D.A.L. Morgan, Rudolf Bongartz, Carla C. Rodenhuis, Conny Vrieling, Bing Oei, Henk Struikmans, Sandra Collette, Caroline Weltens, Jean-Bernard Dubois, Erik Van Limbergen
Publikováno v:
JAMA Oncology, Vol. 3, No 1 (2017) pp. 42-48
Jama Oncology, 3, 42-48
Jama Oncology, 3, 1, pp. 42-48
Jama Oncology, 3, 42-48
Jama Oncology, 3, 1, pp. 42-48
Item does not contain fulltext Importance: Prognostic factors of ipsilateral breast tumor recurrence (IBTR) may change over time following breast-conserving therapy. Objective: The EORTC "boost no boost" trial showed that young age and high-grade inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18758c8080419ed4bc4ddc5344b37bce
https://archive-ouverte.unige.ch/unige:100678
https://archive-ouverte.unige.ch/unige:100678
Autor:
Kwok-Leung Cheung, D.A.L. Morgan, Binafsha Manzoor Syed, Ian O. Ellis, Tulassi Setty, Andrew R. Green, E.C. Paish
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0188528 (2017)
Background Older women are at the greatest risk of breast cancer development and a considerable number present with comorbidities. Although the majority of breast cancers in this age group express oestrogen receptor (ER), which makes endocrine therap
Publikováno v:
Breast Cancer Research and Treatment. 147:671-674
Ductal carcinoma is the commonest histological type found in invasive breast carcinomas and may be associated with worse prognosis, when compared to non-ductal carcinoma. Older patients tend to display more favourable tumour biology than younger pati
Autor:
N. Simpson, H. Kennedy, L. Winterbottom, Kwok-Leung Cheung, D.A.L. Morgan, Binafsha Manzoor Syed, D. W. M. Wong, Simon J Johnston, Ian O. Ellis, Andrew R. Green
Publikováno v:
Annals of Oncology. 23:1465-1471
BACKGROUND A dedicated clinic for older women with early primary breast cancer, established in 1973, has recently evolved into a combined surgical/oncology facility. This study aimed to compare the clinical outcome across these periods. METHODS From
Autor:
Robert C. F. Leonard, L. Winterbottom, Malcolm W.R. Reed, Kwok-Leung Cheung, D.A.L. Morgan, Davina Porock, Ian O. Ellis, K. Barnard
Publikováno v:
The Breast. 20:581-584
Purpose The objectives of the study day were to (i) develop an in-depth understanding around the biology and treatment options; (ii) explore the specific physical and psychosocial needs and consideration including patients perspective; and (iii) gain
Autor:
Ian O. Ellis, Kwok-Leung Cheung, D. W. M. Wong, Waleed Al-Khyatt, Andrew R. Green, D.A.L. Morgan, Binafsha Manzoor Syed, H. Kennedy, Simon J Johnston, L. Winterbottom
Publikováno v:
British Journal of Cancer
Introduction: A Cochrane review of seven randomised trials (N=1571) comparing surgery and primary endocrine therapy (PET) (oestrogen receptor (ER) unselected) shows no difference in overall survival (OS). We report outcome of a large series with ER-p
Publikováno v:
Journal of Geriatric Oncology. 1:103-108
The management of elderly patients with breast cancer is complex. Currently, most of their treatment guidelines have been adapted from studies conducted in younger patients. However, studies have shown that breast cancer in the elderly have distincti
Autor:
Andrew R. Green, D.A.L. Morgan, M. Aleskandrany, E.C. Paish, Kwok-Leung Cheung, G. Okunade, M. Ying, Amit Agrawal, L. Winterbottom, K. Hassell, Ian O. Ellis
Publikováno v:
Critical Reviews in Oncology/Hematology. 72:76-82
Aromatase inhibitors have been shown to be superior to Tamoxifen in several settings. It is unclear whether this superiority extends to their use as primary endocrine therapy in elderly patients with early operable primary breast cancer. Biological c